Lates News

Exact Sciences (EXAS.US): In Q1 2025 financial report, revenue reached $707 million, up from $637.5 million, and beating the expected value of $689.4 million. Earnings per share were -$0.54, better than the previous value of -$0.60, but lower than the expected value of -$0.37.